Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors by Ahmed, Murtaza, von Itzstein, Mitchell S, Sheffield, Thomas, Khan, Shaheen, Fattah, Farjana, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Khan, Saad A, Sultana, Nazima, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E

Get full text

Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer by Gerber, David E, Putnam, William C, Fattah, Farjana J, Kernstine, Kemp H, Brekken, Rolf A, Pedrosa, Ivan, Skelton, Rachael, Saltarski, Jessica M, Lenkinski, Robert E, Leff, Richard D, Ahn, Chul, Padmanabhan, Chyndhri, Chembukar, Vaidehi, Kasiri, Sahba, Kallem, Raja Reddy, Subramaniyan, Indhumathy, Yuan, Qing, Do, Quyen N, Xi, Yin, Reznik, Scott I, Pelosof, Lorraine, Faubert, Brandon, DeBerardinis, Ralph J, Kim, James

Get full text

Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon by Khan, Shaheen, von Itzstein, Mitchell S., Lu, Rong, Bermas, Bonnie L., Karp, David R., Khan, Saad A., Fattah, Farjana J., Park, Jason Y., Saltarski, Jessica M., Gloria‐McCutchen, Yvonne, Xie, Yang, Li, Quan‐Zhen, Wakeland, Edward K., Gerber, David E.

Get full text

Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer by Gupta, Arjun, Saltarski, Jessica M., White, Michael A., Scaglioni, Pier P., Gerber, David E.

Get full text

Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A “Two‐Hit” Autoimmune Toxicity or Clinical Predisposition? by von Itzstein, Mitchell S., Khan, Shaheen, Popat, Vinita, Lu, Rong, Khan, Saad A., Fattah, Farjana J., Park, Jason Y., Bermas, Bonnie L., Karp, David R., Ahmed, Murtaza, Saltarski, Jessica M., Gloria‐McCutchen, Yvonne, Xie, Yang, Li, Quan‐Zhen, Wakeland, Edward K., Gerber, David E.

Get full text

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy by von Itzstein, Mitchell S, Gonugunta, Amrit S, Sheffield, Thomas, Homsi, Jade, Dowell, Jonathan E, Koh, Andrew Y, Raj, Prithvi, Fattah, Farjana, Wang, Yiqing, Basava, Vijay S, Khan, Shaheen, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E

Get full text

Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials by Garcia, Sandra, Saltarski, Jessica M, Yan, Jingsheng, Xie, Xian-Jin, Gerber, David E

Get full text

Concentration-dependent early anti-vascular and anti-tumor effects of itraconazole in non-small cell lung cancer by Gerber, David E., Putnam, William T., Fattah, Farjana J., Kernstine, Kemp H., Brekken, Rolf A., Pedrosa, Ivan, Skelton, Rachael, Saltarski, Jessica M., Lenkinski, Robert E., Leff, Richard, Ahn, Chul, Padmanabhan, Chyndhri, Chembukar, Vaidehi, Kasiri, Sahba, Kallem, Raja Reddy, Subramaniyan, Indhumathy, Yuan, Qing, Do, Quyen N., Xi, Yin, Reznik, Scott I., Pelosof, Lorraine, Faubert, Brandon, DeBerardinis, Ralph J., Kim, James

Get full text